Lisa Wilson | IR |
Hugh O'Dowd | CEO |
Michael Donegan | Interim CFO |
Mark Glickman | Chief Commercial Officer |
Good afternoon, ladies and gentlemen. Thank you for joining us for Therapeutics MD's First Quarter 2020 Financial Results Conference Call. I will now turn the call over to Investor Relations for TherapeuticMDs, Lisa Wilson.
You may begin.
Thank you, operator.